The Staurosporin Nucleus, a Molecule(!) for All Diseases

Loading... Loading video...

Air date:	Tuesday, May 14, 2002, 2:00:00 PM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 89 * This only includes stats from October 2011 and forward.
Category:	Special
Runtime:	00:39:29
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	Mass Spectrometry Interest Group at the NCI-Frederick Although staurosporin was originally identified as a PKC inhibitor, the more targets that this molecular scaffold has been exposed to, the more interesting it has become. Currently there are staurosporin "lookalikes" in clinical trials as drug candidates for topoisomerase I and II inhibition and Cyclin-dependent kinase inhibition. Not areas that one would assume, a priori, that the same basic molecule would be involved. Some thoughts that come to mind involve the possibilities for using such molecules as probes for targets and then the use of sensitive mass spectrometric techniques might well be able to show commonalities in binding sites, thus leading to improved designs for both screens and molecules. These areas will be discussed from both a natural product and also a synthetic perspective. For more information, visit http://msig.ncifcrf.gov

NLM Title:	The staurosporin nucleus, a molecule(!) for all diseases / David Newman.
Author:	Newman, David J. National Institutes of Health (U.S.)
Publisher:
Subjects:	Protein Kinase C--antagonists & inhibitors Staurosporine
Publication Types:	Webcast
Rights:	This is a work of the United States Government. No copyright exists on this material. It may be disseminated freely.
NLM Classification:	QU 143
NLM ID:	101267831
CIT Live ID:	1652
Permanent link:	https://videocast.nih.gov/watch=1652

NIH VideoCasting